298 related articles for article (PubMed ID: 17105986)
1. Endorepellin in vivo: targeting the tumor vasculature and retarding cancer growth and metabolism.
Bix G; Castello R; Burrows M; Zoeller JJ; Weech M; Iozzo RA; Cardi C; Thakur ML; Barker CA; Camphausen K; Iozzo RV
J Natl Cancer Inst; 2006 Nov; 98(22):1634-46. PubMed ID: 17105986
[TBL] [Abstract][Full Text] [Related]
2. Integrin alpha2beta1 is the required receptor for endorepellin angiostatic activity.
Woodall BP; Nyström A; Iozzo RA; Eble JA; Niland S; Krieg T; Eckes B; Pozzi A; Iozzo RV
J Biol Chem; 2008 Jan; 283(4):2335-43. PubMed ID: 18024432
[TBL] [Abstract][Full Text] [Related]
3. Role of tyrosine phosphatase SHP-1 in the mechanism of endorepellin angiostatic activity.
Nyström A; Shaik ZP; Gullberg D; Krieg T; Eckes B; Zent R; Pozzi A; Iozzo RV
Blood; 2009 Nov; 114(23):4897-906. PubMed ID: 19789387
[TBL] [Abstract][Full Text] [Related]
4. Endorepellin, the angiostatic module of perlecan, interacts with both the α2β1 integrin and vascular endothelial growth factor receptor 2 (VEGFR2): a dual receptor antagonism.
Goyal A; Pal N; Concannon M; Paul M; Doran M; Poluzzi C; Sekiguchi K; Whitelock JM; Neill T; Iozzo RV
J Biol Chem; 2011 Jul; 286(29):25947-62. PubMed ID: 21596751
[TBL] [Abstract][Full Text] [Related]
5. Endorepellin evokes autophagy in endothelial cells.
Poluzzi C; Casulli J; Goyal A; Mercer TJ; Neill T; Iozzo RV
J Biol Chem; 2014 Jun; 289(23):16114-28. PubMed ID: 24737315
[TBL] [Abstract][Full Text] [Related]
6. Endorepellin causes endothelial cell disassembly of actin cytoskeleton and focal adhesions through alpha2beta1 integrin.
Bix G; Fu J; Gonzalez EM; Macro L; Barker A; Campbell S; Zutter MM; Santoro SA; Kim JK; Höök M; Reed CC; Iozzo RV
J Cell Biol; 2004 Jul; 166(1):97-109. PubMed ID: 15240572
[TBL] [Abstract][Full Text] [Related]
7. Endorepellin laminin-like globular 1/2 domains bind Ig3-5 of vascular endothelial growth factor (VEGF) receptor 2 and block pro-angiogenic signaling by VEGFA in endothelial cells.
Willis CD; Poluzzi C; Mongiat M; Iozzo RV
FEBS J; 2013 May; 280(10):2271-84. PubMed ID: 23374253
[TBL] [Abstract][Full Text] [Related]
8. Endorepellin, the C-terminal angiostatic module of perlecan, enhances collagen-platelet responses via the alpha2beta1-integrin receptor.
Bix G; Iozzo RA; Woodall B; Burrows M; McQuillan A; Campbell S; Fields GB; Iozzo RV
Blood; 2007 May; 109(9):3745-8. PubMed ID: 17197432
[TBL] [Abstract][Full Text] [Related]
9. Conditional expression of endorepellin in the tumor vasculature attenuates breast cancer growth, angiogenesis and hyaluronan deposition.
Chen CG; Kapoor A; Xie C; Moss A; Vadigepalli R; Ricard-Blum S; Iozzo RV
Matrix Biol; 2023 Apr; 118():92-109. PubMed ID: 36907428
[TBL] [Abstract][Full Text] [Related]
10. Endorepellin affects angiogenesis by antagonizing diverse vascular endothelial growth factor receptor 2 (VEGFR2)-evoked signaling pathways: transcriptional repression of hypoxia-inducible factor 1α and VEGFA and concurrent inhibition of nuclear factor of activated T cell 1 (NFAT1) activation.
Goyal A; Poluzzi C; Willis CD; Smythies J; Shellard A; Neill T; Iozzo RV
J Biol Chem; 2012 Dec; 287(52):43543-56. PubMed ID: 23060442
[TBL] [Abstract][Full Text] [Related]
11. Mast cells produce novel shorter forms of perlecan that contain functional endorepellin: a role in angiogenesis and wound healing.
Jung M; Lord MS; Cheng B; Lyons JG; Alkhouri H; Hughes JM; McCarthy SJ; Iozzo RV; Whitelock JM
J Biol Chem; 2013 Feb; 288(5):3289-304. PubMed ID: 23235151
[TBL] [Abstract][Full Text] [Related]
12. Endorepellin, a novel inhibitor of angiogenesis derived from the C terminus of perlecan.
Mongiat M; Sweeney SM; San Antonio JD; Fu J; Iozzo RV
J Biol Chem; 2003 Feb; 278(6):4238-49. PubMed ID: 12435733
[TBL] [Abstract][Full Text] [Related]
13. The role of perlecan and endorepellin in the control of tumor angiogenesis and endothelial cell autophagy.
Douglass S; Goyal A; Iozzo RV
Connect Tissue Res; 2015; 56(5):381-91. PubMed ID: 26181327
[TBL] [Abstract][Full Text] [Related]
14. Endostatin and endorepellin: A common route of action for similar angiostatic cancer avengers.
Poluzzi C; Iozzo RV; Schaefer L
Adv Drug Deliv Rev; 2016 Feb; 97():156-73. PubMed ID: 26518982
[TBL] [Abstract][Full Text] [Related]
15. Antitumor interaction of short-course endostatin and ionizing radiation.
Hanna NN; Seetharam S; Mauceri HJ; Beckett MA; Jaskowiak NT; Salloum RM; Hari D; Dhanabal M; Ramchandran R; Kalluri R; Sukhatme VP; Kufe DW; Weichselbaum RR
Cancer J; 2000; 6(5):287-93. PubMed ID: 11079167
[TBL] [Abstract][Full Text] [Related]
16. Dual-function synthetic peptide derived from BMP4 for highly efficient tumor targeting and antiangiogenesis.
Choi SH; Lee JY; Suh JS; Park YS; Chung CP; Park YJ
Int J Nanomedicine; 2016; 11():4643-4656. PubMed ID: 27695323
[TBL] [Abstract][Full Text] [Related]
17. Augmentation of radiation response with the vascular targeting agent ZD6126.
Hoang T; Huang S; Armstrong E; Eickhoff JC; Harari PM
Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1458-65. PubMed ID: 16488554
[TBL] [Abstract][Full Text] [Related]
18. Endorepellin evokes an angiostatic stress signaling cascade in endothelial cells.
Kapoor A; Chen CG; Iozzo RV
J Biol Chem; 2020 May; 295(19):6344-6356. PubMed ID: 32205445
[TBL] [Abstract][Full Text] [Related]
19. Tie2-mediated vascular remodeling by ferritin-based protein C nanoparticles confers antitumor and anti-metastatic activities.
Choi YS; Jang H; Gupta B; Jeong JH; Ge Y; Yong CS; Kim JO; Bae JS; Song IS; Kim IS; Lee YM
J Hematol Oncol; 2020 Sep; 13(1):123. PubMed ID: 32928251
[TBL] [Abstract][Full Text] [Related]
20. Endorepellin-evoked Autophagy Contributes to Angiostasis.
Goyal A; Gubbiotti MA; Chery DR; Han L; Iozzo RV
J Biol Chem; 2016 Sep; 291(37):19245-56. PubMed ID: 27435676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
